Baird analyst Catherine Ramsey Schulte lowered the firm’s price target on Bio-Techne (TECH) to $51 from $68 and keeps an Outperform rating on ...

This was the stock's third consecutive day of losses.

Leerink Partners analyst Puneet Souda maintained a Buy rating on Bio-Techne (TECH – Research Report) yesterday and set a price target of ...

Shares of Bio-Techne Corp. TECH rose 2.96% to $50.72 Friday, on what proved to be an all-around positive trading session for ...

Fintel reports that on April 8, 2025, Keybanc downgraded their outlook for Bio-Techne (NasdaqGS:TECH) from Overweight to ...

Bio-Techne TECH shares ended the last trading session 10.8% higher at $54.07. The jump came on an impressive volume with a higher-than-average number of shares changing hands in the session. This ...